A free consultation can be useful even when you are not ready to begin treatment—provided you know what to ask. Bailey Health Solutions gives prospective patients several concrete starting points: an in-person or telehealth evaluation, review of blood work, home delivery of compounded medication with B-12, and optional office visits. But the most consequential questions are not all answered online. What exactly would be prescribed? Which pharmacy would fill it? What does the monthly charge cover, and what happens if you decide not to continue?
This review examines Bailey’s public documentation consulted October 19, 2026, as preparation for that conversation, not as a treatment recommendation. The business advertises integrative healthcare from St. Augustine, Florida, alongside its weight-loss program. Its offer has useful specifics, including a published price and a described care sequence. The gaps are equally practical: the consulted material does not identify the dispensing pharmacy, establish the precise compounded formulation, list eligible states or explain cancellation and refund procedures. Those omissions call for confirmation, not assumptions that a service is unavailable.
At a glance
- Advertised program price
- Compounded GLP-1 with B-12 is advertised at a regular $389 per month, with $50 off the first month, month-to-month pricing, no contracts, no added fees and no membership fees.Sources: [7]
- Initial consultation
- The advertised free initial visit includes consultation, questions about compounded GLP products with B-12, examination of current physical health and review of recent blood tests.Sources: [7]
- Medication and delivery
- Bailey describes ordering compounded GLP medication with B-12 for home shipment after reviewing blood work and determining candidacy; the exact active ingredient and pharmacy are not identified in the consulted offer.Sources: [7]
- Location and reach
- The clinic lists 224 Southpark Circle East, St. Augustine, Florida 32086, and says medication can be shipped to most states without naming them.
- Support options
- Bailey advertises practitioner monitoring, optional weekly visits and an invitation to call or text at any time, but does not publish a guaranteed response time.Sources: [7]
Start with the medication’s identity, not the program label
The first question for Bailey is unusually basic: “What exact medication would you prescribe for me?” The offer describes “Compounded GLP-1 with B-12,” and its process describes an injection. Although the page title mentions semaglutide, the body uses broader GLP or GLP-1 wording. That does not establish the active ingredient, concentration, presentation or quantity a particular patient would receive. Ask for those details in writing, together with the name and location of the pharmacy that would prepare or dispense it.
That distinction matters because a program name is not a complete medication description. The consulted pages do not identify the pharmacy or establish the formulation’s relationship to an approved product. Our guide to asking what the medicine actually is can help organize this discussion. Bailey’s inclusion of B-12 identifies part of its advertised offering; it does not, by itself, document an additional clinical benefit or establish that the preparation matches a medication studied elsewhere.
FDA states that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. Nonapproval alone does not demonstrate clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. A useful consultation question is how the proposed preparation addresses your needs—not simply whether the clinic offers compounding.
Use the free visit to understand the actual evaluation
Bailey says the first weight-loss visit can take place in the office or through telehealth. The discussion covers current physical health, weight-loss goals and previous attempts to lose weight. Its free-visit description also includes answering questions about the compounded B-12 preparation, examining current health and reviewing recent blood tests. This provides a reasonable agenda for the appointment, but it does not mean a prescription is assured or that every subsequent evaluation service is free.
The advertised process calls for a weight-loss laboratory panel if blood work has not been completed within the past year. Bailey then describes receiving and reviewing the results before ordering medication for someone considered a good candidate. Ask which tests make up that panel, whether your existing results are acceptable, where new testing occurs and who pays. The public offer does not itemize the panel or clearly explain whether new or repeat laboratory work is included in the monthly charge.
Bailey’s candidate examples include people with 25 or more pounds to lose, PCOS or type 2 diabetes, as well as people ready to change their diet or struggling to maintain weight loss. These are broad examples, not automatic approval criteria. Ask the evaluating clinician to explain the program’s actual assessment standards and exclusions. NIDDK emphasizes discussing current medicines, supplements, allergies and pregnancy plans; this review cannot determine individual eligibility.
Turn the monthly price into a written cost checklist
Bailey publishes a regular price of $389 per month for its compounded GLP-1 with B-12 program and advertises $50 off the first month. It also states “No contracts,” “No added fees,” “No membership fees” and “Month to month pricing.” Those are meaningful commercial claims, not a detailed billing agreement. The consulted documentation does not specify charge dates, automatic renewal, advance collection, cancellation steps or refund rules. Month-to-month language should not be treated as a promise of a refund.
Ask for a written explanation of what the advertised price buys. In particular, confirm laboratory charges, shipping, injection materials, optional office visits and whether medication quantity or formulation changes affect the charge. The absence of an itemized breakdown should not erase Bailey’s no-added-fees claim, but that claim still needs to be reconciled with the actual services you expect to use. The following checklist turns the published offer into questions that can be answered before payment.
The clinic’s homepage also advertises acceptance of many insurance plans and available payment plans. It does not expressly connect either statement to the GLP-1 program. Do not assume the monthly package is covered, or that installment financing is offered for it. Ask Bailey and your health plan separately about applicable coverage. For additional preparation, use our questions beyond the monthly price, especially when comparing a package with separately billed care.
| Topic | What Bailey documents | Question to resolve |
|---|---|---|
| Initial visit | Advertised as free | Does any testing ordered during the visit create a separate charge? |
| Program price | $389 per month regularly; $50 off the first month | When is the first payment collected and when does the next charge occur? |
| Included services | No added fees or membership fees advertised | Are labs, supplies, shipping and optional visits all included? |
| Ongoing billing | Month-to-month pricing; no contracts | Is renewal automatic, and how do I stop the next charge? |
| Insurance and payment plans | Homepage mentions both generally | Does either option apply specifically to this GLP-1 program? |
Identify who will evaluate, prescribe and follow up
Bailey publishes a multidisciplinary team, but a team roster is not a patient-specific assignment. The site identifies Jason Bailey as a D.C., says he has practiced since 1998 and reports that he moved his practice from Miami to St. Augustine in 2015. It identifies Chastity Haltam as an APRN, with bachelor’s and master’s nursing education at Chamberlain University. These are the provider’s credential descriptions; they were not independently verified for this review.
The roster also identifies Rachel Lahav as a physician assistant whose specialties include weight loss, and Zehra Cumber as a D.O. educated at Nova Southeastern University. These credentials represent different professional roles: a D.C. is not the same credential as a medical or osteopathic physician, and an APRN or PA should not automatically be described as a physician. Ask who will conduct your evaluation, who will prescribe and who will review concerns between appointments.
The weight-loss page promises close practitioner monitoring and describes later discussion of a customized diet plan with a health coach after the program’s target-dose stage. That establishes an advertised support component, but not a visit schedule or a clear division of responsibilities. Before enrolling, ask when clinician follow-up occurs, how it is arranged and whether the health coach and prescribing professional communicate about your care. A general promise of monitoring is less actionable than named contacts and scheduled checkpoints.
Check state access before planning around home delivery
Bailey’s physical office is at 224 Southpark Circle East in St. Augustine, Florida 32086. It offers telehealth visits and says medication can be shipped to “most states,” but the consulted page does not name those states. That wording should not be read as nationwide availability. Give the office your state of residence before scheduling and ask whether it can provide both the clinical visit and the proposed prescription there, rather than asking only whether a package can be mailed.
The described sequence is review of blood work, a candidacy decision, then ordering and shipment of compounded medication with B-12 to the patient’s residence. The public material does not establish the carrier, preparation time, dispatch schedule, arrival estimate, package tracking or handling of lost and damaged shipments. It also does not define the supply quantity per shipment. Ask who owns each step and when to contact the clinic if the expected delivery does not appear.
Temperature handling deserves a direct answer before the first delivery. FDA advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and contacting the provider or dispensing pharmacy to resolve the concern. This is general FDA guidance, not evidence that Bailey has had shipping problems. Our delivery questions checklist can help you request an appropriate contact and resolution process before a package is on the way.
Separate available support from guaranteed access
After medication is ordered, Bailey describes a return office visit or telehealth meeting for staff to demonstrate the injection process. Local patients also have the option of coming to the office weekly for their injection. The page separately labels weekly visits as available but not required. These are useful choices to ask about, particularly if you prefer in-person instruction. Confirm appointment availability and how the optional visits fit within the advertised package rather than assuming an unlimited drop-in service.
The program invites patients to call or text the office at any time and says it will be responsive. Its published office hours are Monday through Friday, 9 a.m. to noon and 2 p.m. to 6 p.m. An invitation to send a message outside those hours does not establish around-the-clock clinical staffing. Ask who reads messages, how a clinical concern reaches the prescribing professional, and what response interval patients should ordinarily expect.
The listed office telephone is (904) 342-4941, and the contact page offers a form requesting name, email, phone number and service of interest. Those are documented entry points, not evidence of a patient portal or a dedicated urgent-care channel. Our guide to support after the first prescription helps distinguish administrative questions from clinical follow-up. Bailey’s public material does not confirm language interpretation, Spanish-language care or a separate after-hours clinical arrangement.
Read the forms as carefully as the program page
Two documentation inconsistencies are worth resolving without overstating what they mean. Bailey’s homepage says “All Ages Welcome,” while terms bearing an October 1, 2023 effective date say its services, website and communications are not intended for people under 18. The scope of those statements is not reconciled. This review is for adults; neither statement should be used to infer that the GLP-1 program accepts minors. Ask the clinic for the program-specific age policy if that question is relevant.
There is also a naming difference. The website and terms identify Bailey Health Solutions, while the contact form’s marketing-text consent names Bailey Spine & Wellness LLC. The consulted documents do not explain their legal relationship. This does not establish wrongdoing, but patients should know which entity provides care, bills them, holds records and sends communications. Request that explanation before signing forms if the documents presented to you use different names.
The terms say SMS consent is not a condition of receiving services, and replying STOP ends SMS messages unless the person opts in again. That is a communications instruction, not a treatment-cancellation procedure. The privacy notice says mobile numbers and SMS opt-in data are not sold, rented or shared for third-party promotional purposes. It also describes electronic-record access, requests to send records to a third party and reasonable requests for privacy-preserving communications.
Ask what success and continuing care would mean
Bailey presents itself as an integrative practice combining medical and natural approaches tailored to individual patients. Its weight-loss page also makes broad promotional statements about health benefits. Those descriptions explain the practice’s positioning; they are not measured outcomes for its compounded program. Ask the treating professional how response will be assessed, how tolerability will be reviewed and what would prompt reconsideration of the plan. A useful answer should go beyond a projected number on the scale.
Clinical studies of particular medications do not establish outcomes for Bailey’s preparation, a vitamin blend or an individual patient. This review therefore does not attach trial weight-loss percentages to the clinic’s offer. NIDDK describes medication as accompanying healthy eating and physical activity, with treatment duration depending on response and side effects. Bailey’s advertised health-coach discussion is relevant to that conversation, but its public description does not establish the frequency or duration of ongoing nutritional support.
Finally, ask what happens when treatment changes or ends. The month-to-month advertisement does not explain continuity of care, final follow-up, record transfer or unused medication and refund questions. Bailey’s terms say website content is informational and does not establish a provider-patient relationship. An actual consultation should clarify when that relationship begins and what responsibilities follow. Before authorizing a charge, request the care plan and billing terms together so neither is left to inference.
Questions & answers
Can I have Bailey’s free consultation without being guaranteed medication?
Yes—the advertised process separates the initial visit from the later prescribing decision. Bailey describes discussing your health and goals, reviewing blood work and ordering medication only if you are considered a good candidate. The free-visit description includes consultation and review of recent tests, but does not clearly establish the price of newly ordered laboratory work. Confirm that distinction before the visit.
Does Bailey identify the exact compounded drug or pharmacy online?
Not in the consulted program documentation. The page title mentions semaglutide, but the offer itself uses broader wording about compounded GLP or GLP-1 medication with B-12. It does not identify the pharmacy, concentration or shipment quantity. Ask for the complete prescription description and pharmacy contact before comparing this offer with a named FDA-approved product or another compounded program.
Is the $389 monthly price an insurance copay?
The program advertises $389 per month as its regular price, with $50 off the first month; it does not describe that amount as an insurance copay. Although Bailey’s homepage mentions many accepted insurance plans and payment plans, the consulted pages do not link those options specifically to GLP-1 treatment. Ask whether any service is submitted to insurance and what you would owe regardless of coverage.
Do I have to visit the St. Augustine office every week?
Bailey explicitly describes weekly visits as optional, not required. It also says the initial evaluation and injection demonstration can occur through telehealth, and local patients may come to the office weekly for injections. Whether remote care is available where you live still needs confirmation: “most states” is not a state-by-state availability list, and the public material does not detail jurisdiction-specific access.
Can I cancel treatment by texting STOP?
Do not treat STOP as a treatment-cancellation request. Bailey’s terms use that instruction to end SMS communications. Separately, the program advertises no contracts and month-to-month pricing, but the consulted documentation does not explain cancellation deadlines, renewal handling or refunds. Ask for the specific method to end participation and stop future charges, and request confirmation that the clinic has received your instruction.
Does being able to text anytime mean Bailey provides 24-hour clinical support?
No such coverage is established by the public wording. Bailey invites calls and texts at any time and promises responsiveness, while its listed office hours are weekdays, 9 a.m.–noon and 2–6 p.m. Ask about expected response times, who answers medication questions and what arrangements apply outside office hours. The advertised invitation to send a message is not a guaranteed clinical response window.
Our assessment
Bailey Health Solutions documents more than a simple medication checkout: a free initial visit, laboratory review before ordering, injection instruction, practitioner monitoring and optional local visits. Its published regular price and first-month discount also give prospective patients a concrete basis for discussion. The central unresolved issue is specificity. Before enrolling, obtain the exact medication and pharmacy, confirmation of state access, an itemized explanation of inclusions, and written renewal, cancellation and refund terms. Clarify who will prescribe and how clinical questions will be handled. The age-policy and business-name discrepancies merit straightforward explanations, not speculation. For adults considering this program, the most useful next step is a fact-finding consultation without assuming that the free visit guarantees a prescription, that general insurance acceptance covers treatment or that month-to-month pricing answers every exit question.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Bailey Health Solutions — official website ↗
- Bailey Health Solutions — contact ↗
- Bailey Health Solutions — glp1weightloss ↗
- Bailey Health Solutions — terms and conditions ↗
- Bailey Health Solutions — meet the team ↗
- Bailey Health Solutions — notice of privacy practices ↗